
|Videos|May 7, 2021
Focusing on 24-month data of the PALADIN study
Author(s)OTE Staff Reports, David Hutton
Dr Michael A. Singer speaks on the highlights of his presentation focusing on IOP in the PALADIN 24-month data intravitreal steroid (ILUVIEN).
Advertisement
Dr Michael A. Singer of the Medical Center Ophthalmology Associates in San Antonio, Texas, speaks on the highlights of his presentation focusing on intraocular pressure (IOP) in the PALADIN 24-month data intravitreal steroid (ILUVIEN), presented during ARVO 2021.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
ESCRS 2026: Q&A: What early real-world data reveal about the TECNIS Odyssey
2
The importance of treating EBMD before cataract surgery
3
Laru-zova meets primary endpoint in pivotal VISTA trial for X-linked retinitis pigmentosa
4
"Time is vision": EURETINA President Nicole Eter, MD, previews the 2026 congress
5









